Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Infections × Lenalidomide × Clear all

Sponsor

Conditions

Multiple Myeloma 132 Leukemia, Lymphocytic, Chronic, B-Cell 37 Lymphoma, Large B-Cell, Diffuse 23 Lymphoma, Follicular 21 Lymphoma, Non-Hodgkin 19 Lymphoma, Mantle-Cell 19 Lymphoma 19 Leukemia 19 Neoplasms, Plasma Cell 18 Recurrence 17 Myelodysplastic Syndromes 11 Lymphoma, B-Cell, Marginal Zone 11 Leukemia, Myeloid, Acute 11 Smoldering Multiple Myeloma 8 Waldenstrom Macroglobulinemia 7 Prostatic Neoplasms 7 Lymphoma, Large-Cell, Anaplastic 5 Hodgkin Disease 5 Sezary Syndrome 4 Mycosis Fungoides 4 Lymphoma, T-Cell, Peripheral 4 Lymphoma, B-Cell 4 Immunoblastic Lymphadenopathy 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Polycythemia Vera 3 Lymphoma, T-Cell, Cutaneous 3 Lymphoma, T-Cell 3 Lymphoma, Extranodal NK-T-Cell 3 Leukemia, Myelomonocytic, Chronic 3 Immunoglobulin Light-chain Amyloidosis 3

Interventions

Daptomycin 2 threonic acid 1 telavancin 1 telaprevir 1 soybean oil, phospholipid emulsion 1 plerixafor 1 peginterferon alfa-2a 1 human papillomavirus vaccine, L1 type 16, 18 1 fludarabine phosphate 1 Whole-Body Irradiation 1 Voriconazole 1 Trimethoprim, Sulfamethoxazole Drug Combination 1 Trimethoprim 1 Tacrolimus 1 Sulfamethoxazole 1 Sirolimus 1 Ribavirin 1 Peripheral Blood Stem Cell Transplantation 1 Ofloxacin 1 Methotrexate 1 Melphalan 1 Magnesium Sulfate 1 Human Papillomavirus Recombinant Vaccine nonavalent 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Hematopoietic Stem Cell Transplantation 1 Granulocyte Colony-Stimulating Factor 1 Fluconazole 1 Filgrastim 1 Etoposide 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡